RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update

30 Mar 2020 - Yahoo News
SOUTH SAN FRANCISCO, Calif., March 30, 2020 -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,.
usx:rapt

---

RAPT Therapeutics Announces Management Promotions

4 Mar 2020 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the promotions of Paul Kassner, ...
usx:rapt

---

RAPT Therapeutics Announces Upcoming Investor Conference Presentations

19 Feb 2020 - Yahoo News
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering,.
usx:rapt

---

RAPT Therapeutics Announces Pricing of $75 Million Public Offering

7 Feb 2020 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the pricing of its underwritten ...
usx:rapt

---

RAPT Therapeutics Announces Proposed Offering of Common Stock

4 Feb 2020 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that it has commenced an underwritten ...
usx:rapt

---

We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth

31 Jan 2020 - Yahoo News
We can readily understand why investors are attracted to unprofitable companies. For example, although...
usx:rapt

---

RAPT Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

7 Jan 2020 - Yahoo News
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2020 -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering,.
usx:rapt

---

RAPT Therapeutics to be Added to the Russell 2000® and Russell Microcap® Indices

16 Dec 2019 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that the Company will be added ...
usx:rapt

---

RAPT Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights

11 Dec 2019 - Yahoo News
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2019 -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,.
usx:rapt

---

RAPT Therapeutics Appoints Mary Ann Gray, Ph.D., to Board of Directors

10 Dec 2019 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that Mary Ann Gray, Ph.D., ...
usx:rapt

---